| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |